In conclusion, modalities that increase CD8+ and CD4+ T lymphocyte responses, including the protein products produced by innate immune cells, such as eosinophils and ILC2s, may increase anti-tumor responses and reduce tumor growth. This evidence concerns the gene CD8A and neoplasm.